These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 29617282)

  • 21. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
    Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
    Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unraveling the molecular mechanism of novel leukemia mutations on NTRK2 (A203T & R458G) and NTRK3 (E176D & L449F) genes using molecular dynamics simulations approach.
    M Al-Subaie A; Kamaraj B; Ahmad F; Alsamman K
    F1000Res; 2023; 12():345. PubMed ID: 39119195
    [No Abstract]   [Full Text] [Related]  

  • 23. Atypical cellular responses mediated by intracellular constitutive active TrkB (NTRK2) kinase domains and a solely intracellular NTRK2-fusion oncogene.
    Gupta R; Dittmeier M; Wohlleben G; Nickl V; Bischler T; Luzak V; Wegat V; Doll D; Sodmann A; Bady E; Langlhofer G; Wachter B; Havlicek S; Gupta J; Horn E; Lüningschrör P; Villmann C; Polat B; Wischhusen J; Monoranu CM; Kuper J; Blum R
    Cancer Gene Ther; 2024 Sep; 31(9):1357-1379. PubMed ID: 39039193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Genomic and Proteomic Profiles of NTRK Genes and Trk Receptors in Liver Hepatocellular Carcinoma.
    Wang H; Qi L; Zhong C; Fang X; Yuan Y
    Clin Med Insights Oncol; 2023; 17():11795549231180840. PubMed ID: 37456611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Larotrectinib, a selective tropomyosin receptor kinase inhibitor for adult and pediatric tropomyosin receptor kinase fusion cancers.
    Farago AF; Demetri GD
    Future Oncol; 2020 Mar; 16(9):417-425. PubMed ID: 32129093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The trk family of oncogenes and neurotrophin receptors.
    Lamballe F; Klein R; Barbacid M
    Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRK Inhibition: A New Tumor-Agnostic Treatment Strategy.
    Kummar S; Lassen UN
    Target Oncol; 2018 Oct; 13(5):545-556. PubMed ID: 30276762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Trk family of neurotrophin receptors.
    Barbacid M
    J Neurobiol; 1994 Nov; 25(11):1386-403. PubMed ID: 7852993
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Gambella A; Senetta R; Collemi G; Vallero SG; Monticelli M; Cofano F; Zeppa P; Garbossa D; Pellerino A; Rudà R; Soffietti R; Fagioli F; Papotti M; Cassoni P; Bertero L
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular LINGO-1 negatively regulates Trk neurotrophin receptor signaling.
    Meabon JS; de Laat R; Ieguchi K; Serbzhinsky D; Hudson MP; Huber BR; Wiley JC; Bothwell M
    Mol Cell Neurosci; 2016 Jan; 70():1-10. PubMed ID: 26546150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trk receptor tyrosine kinases in metastasis and cancer therapy.
    Regua AT; Doheny D; Arrigo A; Lo HW
    Discov Med; 2019 Oct; 28(154):195-203. PubMed ID: 31928627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of a fluorinated quinazoline-based type-II Trk inhibitor as a scaffold for PET radiotracer development.
    Bernard-Gauthier V; Mahringer A; Vesnaver M; Fricker G; Schirrmacher R
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2771-2775. PubMed ID: 28476569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancer.
    Federman N; McDermott R
    Expert Rev Clin Pharmacol; 2019 Oct; 12(10):931-939. PubMed ID: 31469968
    [No Abstract]   [Full Text] [Related]  

  • 34. Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part I.
    Bailey JJ; Schirrmacher R; Farrell K; Bernard-Gauthier V
    Expert Opin Ther Pat; 2017 Jun; 27(6):733-751. PubMed ID: 28270010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel in-cell ELISA method for screening of compounds inhibiting TRKA phosphorylation, using KM12 cell line harboring TRKA rearrangement.
    Pandre MK; Shaik S; Satya Pratap VVV; Yadlapalli P; Yanamandra M; Mitra S
    Anal Biochem; 2018 Mar; 545():78-83. PubMed ID: 29360440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive 'biomarker piggybacking': an examination of reflexive pan-cancer screening with pan-TRK immunohistochemistry.
    Sholl LM; Zheng M; Nardi V; Hornick JL
    Histopathology; 2021 Aug; 79(2):260-264. PubMed ID: 33682174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotrophic receptor tyrosine kinase family members in secretory and non-secretory breast carcinomas.
    Stravodimou A; Voutsadakis IA
    World J Clin Oncol; 2022 Feb; 13(2):135-146. PubMed ID: 35316931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC(NTRK3) to human chromosomes 1q22, 9q22 and 15q25 by fluorescence in situ hybridization.
    Valent A; Danglot G; Bernheim A
    Eur J Hum Genet; 1997; 5(2):102-4. PubMed ID: 9195161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in tyrosine kinase receptor (Trk) expression induced by insulin-like growth factor-1 in cultured dorsal root ganglion neurons.
    Li H; Zhang P; Fu G; Li J; Liu H; Li Z
    Brain Res Bull; 2013 Jan; 90():25-34. PubMed ID: 23022575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFR.
    Fundin BT; Silos-Santiago I; Ernfors P; Fagan AM; Aldskogius H; DeChiara TM; Phillips HS; Barbacid M; Yancopoulos GD; Rice FL
    Dev Biol; 1997 Oct; 190(1):94-116. PubMed ID: 9331334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.